Pharmaco - Press Releases

Date	Title	Company
30-Nov-2021	Biotest AG: Biotest receives approval for Intratect(R) in France	Biotest AG
29-Nov-2021	Relief Reports U.S. Collaboration Partner Identifies Significantly Higher Likelihood of Surviving & Recovering from Critical COVID-19 in Aviptadil Treated Patients Previously Administered Remdesivir	RELIEF THERAPEUTICS Holding AG
29-Nov-2021	MorphoSys AG: Corporate Calendar 2022	MorphoSys AG
26-Nov-2021	7 Key Takeaways from SMi’s 10th Annual Pharmaceutical Microbiology Conference	SMi Group
26-Nov-2021	eHealth-Tec achieves first place in the TOP 100 competition	Zur Rose Group AG
25-Nov-2021	IGEA Pharma N.V.: GBC AG PUBLISHES INITIAL EQUITY RESEARCH REPORT WITH BUY RECOMMENDATION AND PRICE TARGET OF EUR 1.05	IGEA Pharma N.V.
25-Nov-2021	Adjustment of conversion price of convertible bond 2020/2023 (ISIN DE000A3E46M4) to EUR 1.61 after implemented capital increase	aap Implantate AG
25-Nov-2021	Cannovum AG decides to enter the recreational cannabis market	Cannovum AG
25-Nov-2021	Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052	Drägerwerk AG & Co. KGaA
25-Nov-2021	Medios significantly expands its market position in manufacturing with the acquisition of NewCo Pharma Group and taps new growth potentials	Medios AG
25-Nov-2021	Medios acquires NewCo Pharma Group	Medios AG
25-Nov-2021	Science is thriving in UK regions: Government must back them	ABPI
25-Nov-2021	Asklepios Kliniken: Stable business performance in the first nine months of 2021	Asklepios Kliniken
25-Nov-2021	Biotest AG: Biotest AG opens seventh plasma collection centre in Czech Republic	Biotest AG
24-Nov-2021	Todos Medical Announces Exclusive License & Distribution Agreement with T-Cell Protect Hellas S.A. for Tollovid(R) Products Covering 30 Countries in Europe	Todos Medical, Ltd
24-Nov-2021	Relief Therapeutics and InveniAI Sign a Strategic Collaboration Agreement to Identify New Product Development Opportunities using Artificial Intelligence	RELIEF THERAPEUTICS Holding AG
24-Nov-2021	Relief Reports that its U.S. Collaboration Partner has Announced the U.S. Food and Drug Administration has Denied Breakthrough Designation for Aviptadil	RELIEF THERAPEUTICS Holding AG
23-Nov-2021	Drägerwerk AG & Co. KGaA: Net sales and earnings decline in 2022	Drägerwerk AG & Co. KGaA
23-Nov-2021	Biotest AG: Biotest accelerates trimodulin development in hospitalized COVID-19 patients with federal funding in the volume of 29 million EUR	Biotest AG
23-Nov-2021	Gerresheimer AG: Gerresheimer successfully issues promissory loan - transaction again significantly oversubscribed	Gerresheimer AG